Pharmacognosy Reviews logo
Submit
Pharmacognosy ReviewsACADEMIC PUBLISHING
Review

Soluble Epoxide Hydrolase (sEH): A Novel Therapeutic Target in Mitigating the Symptoms of Parkinson’s Disease

1, 2, 2, 2, 2, 2, 2, 2

  1. 1Department of Pharmacology, Jagadguru Sri Shivarathreeswara College of Pharmacy, Jagadguru Sri Shivarathreeswara Academy of Higher Education and Research (Deemed to be University), Mysuru, Karnataka, INDIA.
  2. 2Department of Pharmacology and Pharmacy Practice, Yashwantrao Bhonsale College of Pharmacy (Affiliated to University of Mumbai), Sawantwadi, Sindhudurg, Mumbai, Maharashtra, INDIA.

CORRESPONDENCE

Santhepete Nanjundaiah Manjula

Department of Pharmacology and Pharmacy Practice, Yashwantrao Bhonsale College of Pharmacy (Affiliated to University of Mumbai), Sawantwadi, Sindhudurg, Mumbai, Maharashtra, INDIA.

snmanjula@jssuni.edu.in

Received: 23-03-2026; Accepted: 19-06-2026.

Volume 20, Issue 40 · pp. 154-169 · 2026 · DOI: 10.5530/phrev.20260004

ABSTRACT

Parkinson's Disease (PD) is a progressive neurodegenerative disease characterized by the degeneration of dopaminergic neurons in the substantia nigra, which results in motor control problems. One of the main pathological aspects is the presence of alpha-synuclein aggregates, which are called Lewy bodies. Neuroinflammation is at the centre of PD progression and the contribution of activated microglia, lymphocyte invasion, and increased pro-inflammatory cytokines to neuronal damage. Epoxyeicosatrienoic Acids (EETs), the products of arachidonic acid metabolised through cytochrome P450 epoxygenase, have anti-inflammatory and neuroprotective effects. Specifically, NF-kB activation is inhibited, and BDNF-mediated neuronal survival and neurite outgrowth are enhanced by 11,12-EET. However, EETs are rapidly degraded into less active diols (DHETs) by soluble Epoxide Hydrolase (sEH). sEH inhibition prevents the breakdown of EET, thus elevating their levels and therapeutic potential. The sEH is an attractive approach to inhibiting neuroinflammation and safeguarding dopaminergic neurons in PD.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Mehta, R., Nair, S., Manjunath, S., Manjula, S. N., Ramesh, G., Gunasekaran, S. K., Gavisiddaiah, M., & Mali, P. Y. (2026). Soluble Epoxide Hydrolase (sEH): A Novel Therapeutic Target in Mitigating the Symptoms of Parkinson’s Disease. Pharmacognosy Reviews, 20(40), 154-169. https://doi.org/10.5530/phrev.20260004

    Copyright and licence

    © 2026 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which allows others to share and adapt the work for any purpose, as long as the original authors and source are credited. CC BY 4.0